Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Claire Xu"'
Publikováno v:
International Journal of Population Data Science, Vol 9, Iss 5 (2024)
Objective This systematic review aimed to identify ICD-10 based validated algorithms for chronic conditions using health administrative data. Methods A comprehensive systematic literature search using Ovid MEDLINE, Embase, PsycINFO, Web of Science
Externí odkaz:
https://doaj.org/article/603b48b2f6ca4d5b93c46bd2a33c8c3b
Autor:
Seung Hyuck Jeon, Su-Hyung Park, Jaeho Jung, Xuejun Liu, Hyunjoo Kim, Jaehyoung Jeon, Youngkwang Kim, Gihoon You, Kyungjin Park, Claire Xu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5cc661ff5d654e139c222c89bdc9424a
Publikováno v:
JMIR Research Protocols, Vol 12, p e39093 (2023)
BackgroundIn recent years, mHealth has increasingly been used to deliver behavioral interventions for disease prevention and self-management. Computing power in mHealth tools can provide unique functions beyond conventional interventions in provision
Externí odkaz:
https://doaj.org/article/cbf00d8d2f184d68857dded34b82fbcb
Autor:
Yujun Hao, Yardena Samuels, Qingling Li, Dawid Krokowski, Bo-Jhih Guan, Chao Wang, Zhicheng Jin, Bohan Dong, Bo Cao, Xiujing Feng, Min Xiang, Claire Xu, Stephen Fink, Neal J. Meropol, Yan Xu, Ronald A. Conlon, Sanford Markowitz, Kenneth W. Kinzler, Victor E. Velculescu, Henri Brunengraber, Joseph E. Willis, Thomas LaFramboise, Maria Hatzoglou, Guo-Fang Zhang, Bert Vogelstein, Zhenghe Wang
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-13 (2016)
Cancer cells rely on glutamine to replenish the TCA cycle. Here, the authors show that oncogenic PIK3CAmutations drive this metabolic rewiring in colorectal cancer cells by up-regulating glutamate pyruvate transaminase expression, thus increasing sen
Externí odkaz:
https://doaj.org/article/906e6679c4cc4a669a5f8d6f4ee9c634
Autor:
Jaynier Moya, Marisol Temech, Sergio Parra, Erick Juarez, Reinaldo Hernandez-Loy, Juan C. Moises Gutierrez, Jorge Diaz, Rubaba Hussain, Scott Segal, Claire Xu, Andrew Skingsley, Gretja Schnell, Asma El-Zailik, Jennifer E. Sager, Melissa Aldinger, Elizabeth L. Alexander, Gerard Acloque
Background500 mg intravenous (IV) sotrovimab has been shown to be well tolerated and efficacious against pre-Omicron strains in treating patients with mild to moderate coronavirus disease 2019 (COVID-19) at high risk for disease progression.MethodsTh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7a956eed5166eb2c79e0fb1444f47c3
https://doi.org/10.1101/2023.02.02.23285352
https://doi.org/10.1101/2023.02.02.23285352
Publikováno v:
Journal of Student Research. 11
Autonomous Mobility on Demand (AMoD) is a system consisting of a fleet of centrally-controlled, autonomous vehicles that take customers from their requested origins to their requested destinations. In order to minimize the distance traveled by the fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dac8c278d9164a28d629013d5bdc9c9
https://doi.org/10.47611/jsrhs.v11i4.3606
https://doi.org/10.47611/jsrhs.v11i4.3606
BACKGROUND In recent years, mHealth has increasingly been used to deliver behavioral interventions for disease prevention and self-management. Computing power in mHealth tools can provide unique functions beyond conventional interventions in provisio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::880fa31ed6c47e3240eada05750ccd3b
https://doi.org/10.2196/preprints.39093
https://doi.org/10.2196/preprints.39093
Autor:
Joan Huaqiong Shen, Pengfei Song, Amitkumar Mehta, Vivian Yuan, Zhengyi Wang, Ajay K. Gopal, Linda Lee, Yuan Meng, Claire Xu, Wael A. Harb
Publikováno v:
Blood. 138:3542-3542
Introduction Lemzoparlimab (also known as TJ011133 or TJC4) is a differentiated CD47 IgG4 antibody targeting a distinct CD47 epitope to enable a unique red blood cell sparing property, while retaining strong anti-tumor activity as demonstrated previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de87632c313a81e58aa6ef2e05c4fdc7
https://doi.org/10.1182/blood-2021-150606
https://doi.org/10.1182/blood-2021-150606
Autor:
Francisco Robert, Charles P. Theuer, Huaqiong Joan Shen, Yonggang Zhao, Yan Xing, Bonne J. Adams, Michael S. Gordon, Linda Lee, Elizabeth Mills, James L. Freddo, Ecaterina Elena Dumbrava, Claire Xu, Jerry Wang, James Lawrence, Alicia A Trigeiro, Yuan Meng
Publikováno v:
Journal of Clinical Oncology. 39:2511-2511
2511 Background: CD73 is implicated in tumor resistance to checkpoint immunotherapy (CPI) and plays a critical role in adenosine-mediated immune suppression. Uliledlimab, a differentiated CD73 antibody, inhibits the adenosine pathway in a non-competi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bed6fefdd7c482075e5052dde02f5e7e
https://doi.org/10.1200/jco.2021.39.15_suppl.2511
https://doi.org/10.1200/jco.2021.39.15_suppl.2511
Publikováno v:
RMA Journal. Oct2019, Vol. 102 Issue 2, p38-48. 11p.